APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer

Recruiting N/A Interventional Study
Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 81
Sex
Male
Study type
Interventional
Purpose
Diagnostic
Participants needed
130 (estimated)
Sponsor
Umeå University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical study is to to improve diagnosis, follow-up and treatment for patients with disseminated prostate cancer. The aim is to isolate tumour cells before image diagnostic methods find the metastases. In addition, investigators will use this method to characterise the tumour cells at the "single-cell" level to understand both the metastasis process, early resistance mechanisms …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: -The patient (arm 1 and arm 2) must have a health status that minimises the already low risks of the apheresis treatment, have the logistical possibilities to come to the visits according to the study and be planned for treatment according to standard treatment in Sweden today. …
Contacts

Andreas Josefsson, MD, PhD

+46 70 3805395

andreas.josefsson@umu.se

CONTACT